Hepatitis A and E enterically transmitted virus infections of the liver;Hepatitis A und E - Enteral übertragene virusinfektionen der leber

Therapeutische Umschau

Volumn 61, Issue 8, 2004, Pages 481-486

  Siegl, Günter ^a,b  

^a Inst fur Klin Mikrobiol/Immunol   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS VACCINE;

CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; ENVIRONMENTAL SANITATION; EPIDEMIOLOGICAL DATA; GERMANY; HEPATITIS A; HEPATITIS E; HEPATITIS E VIRUS; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LIVER FAILURE; MEDICAL LITERATURE; PATHOGENESIS; PERSONAL HYGIENE; PICORNAVIRUS; REVIEW; SEROLOGY; VIRUS TRANSMISSION;

EID: 4344576018     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.8.481     Document Type: Review

References (20)

1. Weitz M, Siegl G. Hepatitis A Virus: Structure and molecular virology. pp 15-28. In: Zuckerman AJ, Thomas HC (eds): Viral Hepatitis (second edition). Churchill Livingstone, London, Edinburgh, Philadelphia, Sydney, Toronto, 1998.
2. Siegl G. Hepatitis A-Virus-Infektion. Praxis 2003; 92: 1659-73.
3. Emerson S, Purcell RH. Hepatitis E virus. Rev Med Virol 2003; 13: 145-54.
4. Krawczynski K, Kamili S, Aggarwal R. Global epidemiology and medical aspects of hepatitis E. Forum (Genova) 2001; 11: 166-79.
5. Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among health care workers: risk factors für transmission. Am J Public Health 1993; 83: 1679-84.
6. Rosenblum LS, Villarino ME, Nainan OV et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991; 164: 476-82.
7. Costa-Mattioli M, Monpoeho S, Nicand E et al. Quantification and duration of viremia during hepatitis A infection as determined by real-time RT-PCR. J Viral Hepat 2002; 9: 101-6.
8. Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10 (suppl 1): 63-66.
9. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of Viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000; 356: 1081-2.
10. Steffen R. Hepatitis A in travelers: the European experience. J Infect Dis 1995; 171 (suppl 1) 24-8.
11. Meng XJ, Halbur PG, Shapiro MS et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998; 72: 9714-1.
12. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-3.
13. Glikson M, Galun E, Oren R et al. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine 1992; 71: 14-23.
14. Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000; 15: 473-9.
15. Khuro MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-9.
16. Singh S, Mohanty A, Joshi YK et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70: 37-9.
17. Ramachandra J, Eapen CE, Kang G et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004; 19: 134-8.
18. Vallbracht A, Gabriel P, Maier K et al. Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology 1986; 6: 1308-14.
19. Lemon SM, Thomas D. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196-204.
20. Sagliocca L, Amoroso P, Stroffolini T et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet 1999; 353: 1136-39.